(Nanowerk News) A new insight into RNA regulation has taken researchers a big step forward in understanding how the body creates platelets. Platelets are the smallest of all blood cells; they ...
Hosted on MSN
Cell-free RNA blood test identifies early-stage cancers, monitors treatment resistance and detects tissue damage
Stanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments and tissue injury caused by non-cancerous conditions. The new test analyzes ...
Renovaro Inc. has entered into an exclusive collaboration with Amsterdam University Medical Center to jointly develop blood platelet RNA diagnostics, aiming to enhance disease detection and monitoring ...
This partnership marks an important step forward in the clinical validation and advancement of a promising new approach to disease detection and monitoring. The collaboration will focus on assessing ...
Analyzing RNA from blood platelets detected up to 18 different cancers, at early as well as late stages, with a specificity of 99% in asymptomatic controls. The specificity for symptomatic controls, ...
“CryoEM Structure of the SLFN14 Endoribonuclease Reveals Insight Into RNA Binding and Cleavage,” was published online July 1 in the journal Nature Communications. The study began while Pillon was an ...
When children receive their second measles-mumps-rubella vaccine, around the time they start kindergarten, they gain protection against all three viruses for all or most of their lives. Yet the ...
Max Haeussler, Associate Research Scientist at the UCSC Genomics Institute, will lead a project to build a user-friendly database that brings together a wide range of single cell RNA-sequencing data.
LOS ANGELES, May 13, 2025 (GLOBE NEWSWIRE) -- Renovaro Inc. (RENB), a TechBio leader focused on next-generation diagnostics, drug discovery, and genetically enhanced cancer therapies, today agreed on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results